Clinical trial
Autologous Bone Marrow Mesenchymal Stem Cell and Bone Marrow Mononuclear Cell Infusion in Type 2 Diabetes Mellitus
NCT01719640 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Bone Marrow Mesenchymal Stem Cell and Bone Marrow Mononuclear Cell Infusion in Type 2 Diabetes Mellitus
- Lead sponsor
- Fuzhou General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- January 31, 2020
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.